- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Leverage Leaders
South Korean Pharmaceuticals & Biotech Leverage Leaders
Results
15
15 companies
D&D Pharmatech
Market Cap: ₩4.2t
A clinical-stage biotech company, develops medicines in South Korea and the United States.
A347850
₩98,900.00
7D
7.7%
1Y
620.6%
Peptron
Market Cap: ₩5.9t
Engages in the development of peptide-based medicines.
A087010
₩246,500.00
7D
-3.0%
1Y
146.7%
Hanmi Pharm
Market Cap: ₩5.9t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩462,000.00
7D
2.2%
1Y
66.2%
ALTEOGEN
Market Cap: ₩25.4t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩471,000.00
7D
4.8%
1Y
51.9%
SK Biopharmaceuticals
Market Cap: ₩9.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩123,900.00
7D
-0.6%
1Y
5.9%
Samsung BiologicsLtd
Market Cap: ₩79.7t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,761,000.00
7D
3.9%
1Y
13.6%
Aimed Bio
Market Cap: ₩3.5t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩58,800.00
7D
2.1%
1Y
n/a
Caregen
Market Cap: ₩3.3t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩67,600.00
7D
-5.8%
1Y
122.7%
PharmaResearch
Market Cap: ₩4.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩432,500.00
7D
7.3%
1Y
72.0%
ABL Bio
Market Cap: ₩11.1t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩210,500.00
7D
5.3%
1Y
604.0%
Celltrion
Market Cap: ₩46.6t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩209,750.00
7D
15.9%
1Y
18.2%
LigaChem Biosciences
Market Cap: ₩6.4t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩178,900.00
7D
3.0%
1Y
47.9%
OliX Pharmaceuticals
Market Cap: ₩2.9t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩158,600.00
7D
13.0%
1Y
940.0%
Voronoi
Market Cap: ₩3.7t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩205,000.00
7D
-5.7%
1Y
160.8%
Yuhan
Market Cap: ₩8.5t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩113,100.00
7D
0.6%
1Y
-15.4%